中国科技核心期刊
中国科技论文统计源期刊
中文生物医学期刊文献数据库
中国科学引文数据库(CSCD收录)
中国学术期刊综合评价数据库统计源期刊
《中国学术期刊影响因子年报》统计源期刊
Chinese Journal of Blood Purification ›› 2014, Vol. 13 ›› Issue (06): 437-440.doi: 10.3969/j.issn.1671-4091.2014.06.005
Previous Articles Next Articles
Received:
Revised:
Online:
Published:
Abstract: 【Abstract】Objective To compare the clearance ability for middle molecular uremic toxins, like inflammatory mediators and parathyroid hormone (PTH), in maintenance hemodialysis patients (MHD) of three blood purification modalities and also evaluate the effect of recombinant human erythropoietin (r-HuEPO)in this study. Methods Fifty-four maintenance hemodialysis patients were randomly divided into three groups, namely hemodialysis (HD) group , hemodiafiltration (HDF) group , hemoperfusion (HD+HP) group,eighteen in each group. Routine blood test was checked every 4 weeks and EPO dosage according to the correction of anemia adjusted.The follow-up lasted for three months. The level of C-reactive protein (CRP), PTH, interleukin-6 (IL-6) and indicators of renal anemia were measured at the beginning and just after the trial,while r-HuEPO amount and hematocrit (Hct) ratio (EPO/Hct) was defined as r-HuEPO resistance indicators. Results Before and after the treatment, comparising in group , EPO/Hct, CRP, IL-6, PTH of patients in HDF and HD+HP group decreased obviously (P<0.05), while no significant change in each indicators was observed in HD group(P>0.05); Comparising between groups , rHuEPO dosage , EPO/Hct, CRP, IL-6 and PTH decreased obviously in HD+HP and HDF group and the CRP, IL-6 concentration was evidently lower in HD+HP group (P<0.05).correlation analysis found that CRP, IL-6 and PTH were associated with the EPO/Hct ratio. Conclusions HDF and HD+HP can improve the treatment efficacy and reduce dosage of EPO in uremic patients, while the mechanism probably has part relationship with the improvement of hyperparathyroidism and micro-inflammation status of the population.
Key words: Hemodialysis, Hemoperfusion, Hemodiafiltration, Renal anemia, Erythropoietin
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://www.cjbp.org.cn/EN/10.3969/j.issn.1671-4091.2014.06.005
https://www.cjbp.org.cn/EN/Y2014/V13/I06/437